News ProKidney Corp.

Equities

PROK

KYG7S53R1049

Real-time Estimate Cboe BZX Other stock markets 02:23:22 2024-05-21 pm EDT			5-day change	1st Jan Change
3.66 ^USD	-6.63%		+27.27%	+120.22%

May. 10	ProKidney Q1 Loss Unchanged From Year Earlier	MT
May. 10	ProKidney Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024	07:01am	AQ
ProKidney Reports Business Updates and First Quarter 2024 Financial Results	May. 13	AQ
ProKidney Q1 Loss Unchanged From Year Earlier	May. 10	MT
ProKidney Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 10	CI
ProKidney Reports Business Updates and First Quarter 2024 Financial Results	May. 10	AQ
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations	Mar. 25	AQ
ProKidney Corp. Announces Key Leadership Appointments Strengthening Clinical and Technical Operations	Mar. 25	CI
ProKidney Posts Wider 2023 Loss	Mar. 22	MT
ProKidney Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 22	CI
ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights	Mar. 21	AQ
ProKidney to Participate in Jefferies Biotech on the Bay Summit	Feb. 29	AQ
BofA Securities Downgrades ProKidney to Neutral From Buy, Cuts Price Target to $2 From $8	Jan. 02	MT
Chronic Kidney Disease Pipeline, FDA Approvals, Clinical Trials Developments, Companies 2023 \| Boehringer Ingelheim, Eli Lilly and Company, Reata Pharmaceuticals, Novo Nordisk, Prokidney, and others.	Dec. 05	AQ
ProKidney Corp. Announces Termination of Deepak Jain as Chief Operating Officer	Nov. 30	CI
ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer	Nov. 30	AQ
Prokidney Appoints Nikhil Pereira-Kamath as Chief Business Officer	Nov. 30	CI
ProKidney Files $500 Million Mixed Shelf	Nov. 22	MT
Prokidney Insider Sold Shares Worth $9,498,584, According to a Recent SEC Filing	Nov. 21	MT
ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference	Nov. 21	AQ
Sector Update: Health Care Stocks Advance in Late Afternoon Trading	Nov. 20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News ProKidney Corp.

Equities

PROK

KYG7S53R1049

Summary

Filters